BS
INSIDER · SYRE · Spyre Therapeutics, Inc. · CHIEF FINANCIAL OFFICER
Burrows Scott L
Every open-market transaction filed under this name, Sep 1 to Oct 1.
Filings
11
0 buys · 11 sells
Bought
—
open market, at cost
Sold
$4.5M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 1 | SYRE | Spyre Therapeutics, Inc. | Chief Financial Officer | Sell | 229 | $93.57 | $21K | — |
| Oct 1 | SYRE | Spyre Therapeutics, Inc. | Chief Financial Officer | Sell | 3,071 | $92.95 | $285K | — |
| Oct 1 | SYRE | Spyre Therapeutics, Inc. | Chief Financial Officer | Sell | 2,100 | $91.92 | $193K | — |
| Oct 1 | SYRE | Spyre Therapeutics, Inc. | Chief Financial Officer | Sell | 1,500 | $90.27 | $135K | — |
| Oct 1 | SYRE | Spyre Therapeutics, Inc. | Chief Financial Officer | Sell | 600 | $89.07 | $53K | — |
| Sep 30 | SYRE | Spyre Therapeutics, Inc. | Chief Financial Officer | Sell | 17,500 | $89.89 | $1.6M | — |
| Sep 2 | SYRE | Spyre Therapeutics, Inc. | Chief Financial Officer | Sell | 18,232 | $89.35 | $1.6M | — |
| Sep 1 | SYRE | Spyre Therapeutics, Inc. | Chief Financial Officer | Sell | 200 | $89.04 | $18K | — |
| Sep 1 | SYRE | Spyre Therapeutics, Inc. | Chief Financial Officer | Sell | 2,016 | $88.03 | $177K | — |
| Sep 1 | SYRE | Spyre Therapeutics, Inc. | Chief Financial Officer | Sell | 4,384 | $87.11 | $382K | — |
| Sep 1 | SYRE | Spyre Therapeutics, Inc. | Chief Financial Officer | Sell | 900 | $86.25 | $78K | — |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.